MEDICAL COSTS AVOIDED FOR PREVENTION OF STROKE WITH USE OF NOACS: ESTIMATES FOR THE REAL-WORLD

被引:0
|
作者
Amin, Alpesh
Stokes, Michael
Makenbaeva, Dinara
Wiederkehr, Daniel
Gatt, Elyse
Wu, Ning
Lawrence, John
机构
[1] Bristol Myers Squibb, Plainsboro, NJ USA
[2] Pfizer, New York, NY USA
关键词
D O I
10.1016/S0735-1097(14)60330-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1109-120
引用
收藏
页码:A330 / A330
页数:1
相关论文
共 50 条
  • [21] Real-world use of medical therapy in moderate asymptomatic carotid stenosis
    Bloch, Randall A.
    Ellias, Samia D.
    Caron, Elisa
    Prushik, Scott G.
    Shean, Katie E.
    Conrad, Mark F.
    JOURNAL OF VASCULAR SURGERY, 2024, 80 (04) : 1104 - 1110
  • [22] REAL-WORLD USE OF LORCASERIN BASED ON ELECTRONIC MEDICAL RECORD ANALYSIS
    Choi, J. C.
    Li, X.
    Wang, Z.
    VALUE IN HEALTH, 2016, 19 (03) : A242 - A242
  • [23] Appropriate Interpretation of the Observed NOACs Treatment Effect Size in Real-world Study Reply
    Graham, David J.
    Baro, Elande
    Wernecke, Michael
    Kelman, Jeffrey A.
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (10): : E754 - E755
  • [24] Real-world effectiveness of warfarin therapy for stroke prevention in medicare beneficiaries of all races
    Gage, B
    Birman-Deych, E
    Nilasena, DS
    Radford, MJ
    STROKE, 2005, 36 (02) : 424 - 424
  • [25] Pioglitazone for Secondary Stroke Prevention in Pre-diabetes: Implications for Real-world Practice
    Spence, J. David
    Viscoli, Catherine
    Dearborn-Tomazos, Jennifer
    Furie, Karen
    Ford, Gary
    Young, Lawrence
    Inzucchi, Silvio
    Gorman, Mark
    Lovejoy, Anne
    Kernan, Walter
    STROKE, 2019, 50
  • [26] Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention Based on Real-World Data
    Chi, Nai-Fang
    Wen, Chi-Pang
    Liu, Chung-Hsiang
    Li, Jie-Yuan
    Jeng, Jiann-Shing
    Chen, Chih-Hung
    Lien, Li-Ming
    Lin, Ching-Huang
    Sun, Yu
    Chang, Wei-Lun
    Hu, Chaur-Jong
    Hsu, Chung Y.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (19):
  • [27] Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban
    Camm, A. John
    Coleman, Craig I.
    Larsen, Torben Bjerregaard
    Nielsen, Peter Bronnum
    Tamayo, Sally
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 : S45 - S60
  • [28] Real-world stroke prevention strategies in nonvalvular atrial fibrillation in patients with renal impairment
    Mert, Kadir U.
    Mert, Gurbet O.
    Basaran, Ozcan
    Beton, Osman
    Dogan, Volkan
    Tekinalp, Mehmet
    Aykan, Ahmet C.
    Kalaycioglu, Ezgi
    Bolat, Ismail
    Tasar, Onur
    Safak, Ozgen
    Kalcik, Macit
    Yaman, Mehmet
    Kirma, Cevat
    Biteker, Murat
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 (06) : 428 - 438
  • [29] Cost-effectiveness of HIV Prevention Interventions: Estimates from Real-world Implementation Needed
    Peebles, Kathryn
    Baeten, Jared M.
    ECLINICALMEDICINE, 2019, 10 : 8 - 9
  • [30] Real-World Study Real-World Study of the Use of Azacitidine in Myelodysplasia in Australia
    Enjeti, Anoop
    Ashraf, Asma
    Caillet, Vincent
    Alam, Arif
    Sillar, Jonathan Robert
    Castaldi, Francesco
    Paine, Taliesha
    Keer, Harold N.
    BLOOD, 2022, 140 : 12341 - 12342